4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-038374
Director acquired 2,074 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cole Douglas G. Director | 2021-06-02 | Grant or award | +2,074 | 5,327 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Cole Douglas G. Director | 2021-06-02 | Grant or award · Stock Option (right to buy) | +6,222 | 6,222 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…